Review



processing workflow termed inview metagenome program  (Eurofins)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Eurofins processing workflow termed inview metagenome program
    Processing Workflow Termed Inview Metagenome Program, supplied by Eurofins, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/workflow/inview+metagenome+processing+program+termed+workflow/pm42252802-78-5-0
    Average 86 stars, based on 1 article reviews
    processing workflow termed inview metagenome program - by Bioz Stars, 2026-09
    86/100 stars

    Images

    Related Articles

    Sequencing:

    Article Title: Lowered Abundance of Gut Bacteriophage Species Is Associated With Human Cancer Cachexia.
    Article Snippet: Next, the prepared libraries were sequenced on the Illumina NovaSeq 6000 system (Illumina, San Diego, California, United States) with a run configuration of 2x150 bp paired- end mode (sequencing depth: > 10 Gb, ≥ 10 million read pairs and ≥ 20 million raw reads per sample) at Eurofins (Konstanz, Germany). .. Eurofins offers a rigorous sample processing workflow termed INVIEW metagenome program (all- in- one in- house solution), which is designed to detect and remove host DNA, contaminant sequences, sequence artefacts and low- quality reads that do not meet strict quality control (QC) scores using established guidelines, standards and bioinformatic quality control (QC) tools for quality assurance (QA) of shotgun metagenomic data from stool samples [S20]. ..

    Control:

    Article Title: Lowered Abundance of Gut Bacteriophage Species Is Associated With Human Cancer Cachexia.
    Article Snippet: Next, the prepared libraries were sequenced on the Illumina NovaSeq 6000 system (Illumina, San Diego, California, United States) with a run configuration of 2x150 bp paired- end mode (sequencing depth: > 10 Gb, ≥ 10 million read pairs and ≥ 20 million raw reads per sample) at Eurofins (Konstanz, Germany). .. Eurofins offers a rigorous sample processing workflow termed INVIEW metagenome program (all- in- one in- house solution), which is designed to detect and remove host DNA, contaminant sequences, sequence artefacts and low- quality reads that do not meet strict quality control (QC) scores using established guidelines, standards and bioinformatic quality control (QC) tools for quality assurance (QA) of shotgun metagenomic data from stool samples [S20]. ..



    Similar Products

    86
    Mendeley Ltd reproducible workflow
    Reproducible Workflow, supplied by Mendeley Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/workflow/reproducible+workflow/pmc13264291-6-16-23
    Average 86 stars, based on 1 article reviews
    reproducible workflow - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    86
    Amira Pharmaceuticals workflow
    Workflow, supplied by Amira Pharmaceuticals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/workflow/amira+software+workflow/pmc13266026-271-8-4
    Average 86 stars, based on 1 article reviews
    workflow - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    86
    Pacific Biosciences lima workflow
    Lima Workflow, supplied by Pacific Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/workflow/0+2+lima+v2/pm42312738-49-7-9
    Average 86 stars, based on 1 article reviews
    lima workflow - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    86
    Pacific Biosciences circular consensus sequencing ccs workflow
    Circular Consensus Sequencing Ccs Workflow, supplied by Pacific Biosciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/workflow/circular+consensus+dna+hifi+libraries+sequencing/pm42308296-279-8-17
    Average 86 stars, based on 1 article reviews
    circular consensus sequencing ccs workflow - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    86
    Baxter Healthcare doseedgetm pharmacy workflow manager
    Doseedgetm Pharmacy Workflow Manager, supplied by Baxter Healthcare, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/workflow/doseedgetm+manager+pharmacy+workflow/us12658315-165-11-17
    Average 86 stars, based on 1 article reviews
    doseedgetm pharmacy workflow manager - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    86
    Exosome Diagnostics exosome diagnostic workflow
    Proposed <t>workflow</t> for exosome‑based clinical diagnostics <t>in</t> <t>psoriasis.</t> The workflow follows MISEV2023 guidelines and includes (1) sample collection (plasma, urine or tissue, processed on ice within 1 h); (2) EV separation (differential ultracentrifugation plus iodixanol density gradient); (3) orthogonal quality control (NTA, TEM, EV markers CD9/CD63/CD81/ALIX/TSG101, and exclusion of non‑EV contaminants such as calnexin); (4) molecular profiling (qRT‑PCR or ddPCR for exosomal miRNAs or mRNAs); and (5) clinical interpretation (ROC‑derived cut‑offs, composite scores with PASI/CRP, independent validation). No exosome‑based psoriasis test has yet received regulatory clearance.
    Exosome Diagnostic Workflow, supplied by Exosome Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/workflow/diagnostic+exosome+workflow/pmc13281886-125-0-0
    Average 86 stars, based on 1 article reviews
    exosome diagnostic workflow - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    86
    Novartis experimental workflows
    Proposed <t>workflow</t> for exosome‑based clinical diagnostics <t>in</t> <t>psoriasis.</t> The workflow follows MISEV2023 guidelines and includes (1) sample collection (plasma, urine or tissue, processed on ice within 1 h); (2) EV separation (differential ultracentrifugation plus iodixanol density gradient); (3) orthogonal quality control (NTA, TEM, EV markers CD9/CD63/CD81/ALIX/TSG101, and exclusion of non‑EV contaminants such as calnexin); (4) molecular profiling (qRT‑PCR or ddPCR for exosomal miRNAs or mRNAs); and (5) clinical interpretation (ROC‑derived cut‑offs, composite scores with PASI/CRP, independent validation). No exosome‑based psoriasis test has yet received regulatory clearance.
    Experimental Workflows, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/workflow/experimental+workflows/pm42288212-15-9-1
    Average 86 stars, based on 1 article reviews
    experimental workflows - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    86
    10X Genomics v2 workflow
    Proposed <t>workflow</t> for exosome‑based clinical diagnostics <t>in</t> <t>psoriasis.</t> The workflow follows MISEV2023 guidelines and includes (1) sample collection (plasma, urine or tissue, processed on ice within 1 h); (2) EV separation (differential ultracentrifugation plus iodixanol density gradient); (3) orthogonal quality control (NTA, TEM, EV markers CD9/CD63/CD81/ALIX/TSG101, and exclusion of non‑EV contaminants such as calnexin); (4) molecular profiling (qRT‑PCR or ddPCR for exosomal miRNAs or mRNAs); and (5) clinical interpretation (ROC‑derived cut‑offs, composite scores with PASI/CRP, independent validation). No exosome‑based psoriasis test has yet received regulatory clearance.
    V2 Workflow, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/workflow/pm42288475-416-26-18
    Average 86 stars, based on 1 article reviews
    v2 workflow - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    86
    Sentieon Inc workflow
    Proposed <t>workflow</t> for exosome‑based clinical diagnostics <t>in</t> <t>psoriasis.</t> The workflow follows MISEV2023 guidelines and includes (1) sample collection (plasma, urine or tissue, processed on ice within 1 h); (2) EV separation (differential ultracentrifugation plus iodixanol density gradient); (3) orthogonal quality control (NTA, TEM, EV markers CD9/CD63/CD81/ALIX/TSG101, and exclusion of non‑EV contaminants such as calnexin); (4) molecular profiling (qRT‑PCR or ddPCR for exosomal miRNAs or mRNAs); and (5) clinical interpretation (ROC‑derived cut‑offs, composite scores with PASI/CRP, independent validation). No exosome‑based psoriasis test has yet received regulatory clearance.
    Workflow, supplied by Sentieon Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/workflow/workflow/pm42286715-553-26-22
    Average 86 stars, based on 1 article reviews
    workflow - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    86
    Exosome Diagnostics isolation tei workflow precipitation
    Proposed <t>workflow</t> for exosome‑based clinical diagnostics <t>in</t> <t>psoriasis.</t> The workflow follows MISEV2023 guidelines and includes (1) sample collection (plasma, urine or tissue, processed on ice within 1 h); (2) EV separation (differential ultracentrifugation plus iodixanol density gradient); (3) orthogonal quality control (NTA, TEM, EV markers CD9/CD63/CD81/ALIX/TSG101, and exclusion of non‑EV contaminants such as calnexin); (4) molecular profiling (qRT‑PCR or ddPCR for exosomal miRNAs or mRNAs); and (5) clinical interpretation (ROC‑derived cut‑offs, composite scores with PASI/CRP, independent validation). No exosome‑based psoriasis test has yet received regulatory clearance.
    Isolation Tei Workflow Precipitation, supplied by Exosome Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/workflow/isolation+precipitation+tei+workflow/pm42278575-106-18-17
    Average 86 stars, based on 1 article reviews
    isolation tei workflow precipitation - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    Image Search Results


    Proposed workflow for exosome‑based clinical diagnostics in psoriasis. The workflow follows MISEV2023 guidelines and includes (1) sample collection (plasma, urine or tissue, processed on ice within 1 h); (2) EV separation (differential ultracentrifugation plus iodixanol density gradient); (3) orthogonal quality control (NTA, TEM, EV markers CD9/CD63/CD81/ALIX/TSG101, and exclusion of non‑EV contaminants such as calnexin); (4) molecular profiling (qRT‑PCR or ddPCR for exosomal miRNAs or mRNAs); and (5) clinical interpretation (ROC‑derived cut‑offs, composite scores with PASI/CRP, independent validation). No exosome‑based psoriasis test has yet received regulatory clearance.

    Journal: Clinical, Cosmetic and Investigational Dermatology

    Article Title: Exosomes in Psoriasis: From Pathogenic Mechanisms to Therapeutic Innovations

    doi: 10.2147/CCID.S606845

    Figure Lengend Snippet: Proposed workflow for exosome‑based clinical diagnostics in psoriasis. The workflow follows MISEV2023 guidelines and includes (1) sample collection (plasma, urine or tissue, processed on ice within 1 h); (2) EV separation (differential ultracentrifugation plus iodixanol density gradient); (3) orthogonal quality control (NTA, TEM, EV markers CD9/CD63/CD81/ALIX/TSG101, and exclusion of non‑EV contaminants such as calnexin); (4) molecular profiling (qRT‑PCR or ddPCR for exosomal miRNAs or mRNAs); and (5) clinical interpretation (ROC‑derived cut‑offs, composite scores with PASI/CRP, independent validation). No exosome‑based psoriasis test has yet received regulatory clearance.

    Article Snippet: Exosome diagnostic workflow for psoriasis: 5 steps from collection to validation.

    Techniques: Clinical Proteomics, Control, Biomarker Discovery